The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee. The general function of the committees is to provide advice and recommendations to FDA on regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.
Document
Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments
The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advi...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
83 FR 13493
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments,” thefederalregister.org (March 29, 2018), https://thefederalregister.org/documents/2018-06309/joint-meeting-of-the-arthritis-advisory-committee-and-the-drug-safety-and-risk-management-advisory-committee-notice-of-m.